1. Home
  2. FPI vs BCYC Comparison

FPI vs BCYC Comparison

Compare FPI & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

HOLD

Current Price

$9.83

Market Cap

448.2M

Sector

Real Estate

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$6.94

Market Cap

476.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPI
BCYC
Founded
2013
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
448.2M
476.6M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
FPI
BCYC
Price
$9.83
$6.94
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$18.73
AVG Volume (30 Days)
581.6K
263.3K
Earning Date
10-29-2025
10-30-2025
Dividend Yield
2.45%
N/A
EPS Growth
296.76
N/A
EPS
1.27
N/A
Revenue
$52,990,000.00
$28,339,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.37
$6.03
52 Week High
$12.87
$15.47

Technical Indicators

Market Signals
Indicator
FPI
BCYC
Relative Strength Index (RSI) 44.44 48.01
Support Level $9.73 $6.73
Resistance Level $10.53 $7.28
Average True Range (ATR) 0.15 0.35
MACD -0.02 -0.02
Stochastic Oscillator 13.75 28.26

Price Performance

Historical Comparison
FPI
BCYC

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: